Sections
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 7 |
| 1.1 List of Tables | 5 | 3 |
| 1.2 List of Figures | 8 | 1 |
| 2 Introduction | 9 | 1 |
| 2.1 Liver Cancer Diagnostic Tests Overview | 9 | 1 |
| 3 Products under Development | 10 | 4 |
| 3.1 Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development | 10 | 1 |
| 3.2 Liver Cancer Diagnostic Tests - Pipeline Products by Territory | 11 | 1 |
| 3.3 Liver Cancer Diagnostic Tests - Pipeline Products by Regulatory Path | 12 | 1 |
| 3.4 Liver Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date | 13 | 1 |
| 4 Liver Cancer Diagnostic Tests - Pipeline Products under Development by Companies | 14 | 4 |
| 4.1 Liver Cancer Companies - Pipeline Products by Stage of Development | 14 | 2 |
| 4.2 Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development | 16 | 2 |
| 5 Liver Cancer Diagnostic Tests Companies and Product Overview | 18 | 46 |
| 5.1 Abbott Diagnostics Company Overview | 18 | 1 |
| 5.1.1 Abbott Diagnostics Pipeline Products &Ongoing Clinical Trials Overview | 18 | 5 |
| 5.2 Abcodia Ltd. Company Overview | 23 | 1 |
| 5.2.1 Abcodia Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 23 | 1 |
| 5.3 AXO Science S.A.S. Company Overview | 24 | 1 |
| 5.3.1 AXO Science S.A.S. Pipeline Products &Ongoing Clinical Trials Overview | 24 | 3 |
| 5.4 BioMark Technologies Inc. Company Overview | 27 | 1 |
| 5.4.1 BioMark Technologies Inc. Pipeline Products &Ongoing Clinical Trials Overview | 27 | 1 |
| 5.5 China Sky One Medical, Inc. Company Overview | 28 | 1 |
| 5.5.1 China Sky One Medical, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 28 | 1 |
| 5.6 Digna Biotech, S.L. Company Overview | 29 | 1 |
| 5.6.1 Digna Biotech, S.L. Pipeline Products &Ongoing Clinical Trials Overview | 29 | 2 |
| 5.7 Drexel University Company Overview | 31 | 1 |
| 5.7.1 Drexel University Pipeline Products &Ongoing Clinical Trials Overview | 31 | 2 |
| 5.8 German Cancer Research Center Company Overview | 33 | 1 |
| 5.8.1 German Cancer Research Center Pipeline Products &Ongoing Clinical Trials Overview | 33 | 1 |
| 5.9 Glycotest, Inc. Company Overview | 34 | 1 |
| 5.9.1 Glycotest, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 34 | 1 |
| 5.10 Imperial College London Company Overview | 35 | 1 |
| 5.10.1 Imperial College London Pipeline Products &Ongoing Clinical Trials Overview | 35 | 1 |
| 5.11 IntegraGen SA Company Overview | 36 | 1 |
| 5.11.1 IntegraGen SA Pipeline Products &Ongoing Clinical Trials Overview | 36 | 2 |
| 5.12 Matrix-Bio, Inc. Company Overview | 38 | 1 |
| 5.12.1 Matrix-Bio, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 38 | 2 |
| 5.13 NanoString Technologies, Inc. Company Overview | 40 | 1 |
| 5.13.1 NanoString Technologies, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 40 | 2 |
| 5.14 National Cancer Institute Company Overview | 42 | 1 |
| 5.14.1 National Cancer Institute Pipeline Products &Ongoing Clinical Trials Overview | 42 | 2 |
| 5.15 Oncimmune (USA) LLC Company Overview | 44 | 1 |
| 5.15.1 Oncimmune (USA) LLC Pipeline Products &Ongoing Clinical Trials Overview | 44 | 1 |
| 5.16 Orion Genomics LLC Company Overview | 45 | 1 |
| 5.16.1 Orion Genomics LLC Pipeline Products &Ongoing Clinical Trials Overview | 45 | 1 |
| 5.17 PleX Diagnostics Company Overview | 46 | 1 |
| 5.17.1 PleX Diagnostics Pipeline Products &Ongoing Clinical Trials Overview | 46 | 1 |
| 5.18 ProMIS Neurosciences Inc. Company Overview | 47 | 1 |
| 5.18.1 ProMIS Neurosciences Inc. Pipeline Products &Ongoing Clinical Trials Overview | 47 | 2 |
| 5.19 Proplex Technologies, Llc Company Overview | 49 | 1 |
| 5.19.1 Proplex Technologies, Llc Pipeline Products &Ongoing Clinical Trials Overview | 49 | 1 |
| 5.20 Proteome Sciences Plc Company Overview | 50 | 1 |
| 5.20.1 Proteome Sciences Plc Pipeline Products &Ongoing Clinical Trials Overview | 50 | 2 |
| 5.21 Roche Diagnostics International Ltd. Company Overview | 52 | 1 |
| 5.21.1 Roche Diagnostics International Ltd. Pipeline Products &Ongoing Clinical Trials Overview | 52 | 1 |
| 5.22 TrovaGene, Inc. Company Overview | 53 | 1 |
| 5.22.1 TrovaGene, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 53 | 2 |
| 5.23 University of Rochester Company Overview | 55 | 1 |
| 5.23.1 University of Rochester Pipeline Products &Ongoing Clinical Trials Overview | 55 | 1 |
| 5.24 Ventana Medical Systems, Inc. Company Overview | 56 | 1 |
| 5.24.1 Ventana Medical Systems, Inc. Pipeline Products &Ongoing Clinical Trials Overview | 56 | 1 |
| 5.25 Viomics Inc. Company Overview | 57 | 1 |
| 5.25.1 Viomics Inc. Pipeline Products &Ongoing Clinical Trials Overview | 57 | 1 |
| 5.26 XEPTAGEN SpA Company Overview | 58 | 1 |
| 5.26.1 XEPTAGEN SpA Pipeline Products &Ongoing Clinical Trials Overview | 58 | 5 |
| 5.27 Xiamen Zeesan Biotech Co.,Ltd Company Overview | 63 | 1 |
| 5.27.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products &Ongoing Clinical Trials Overview | 63 | 1 |
| 6 Liver Cancer Diagnostic Tests - Recent Developments | 64 | 27 |
| 6.1 Aug 12, 2016: ProMIS Neurosciences Announces Second Quarter 2016 Results | 64 | 1 |
| 6.2 Aug 09, 2016: Blueprint Medicines Reports Second Quarter 2016 Financial Results | 65 | 1 |
| 6.3 Aug 04, 2016: Trovagene Reports Second Quarter 2016 Financial Results and Accomplishments | 66 | 1 |
| 6.4 Aug 04, 2016: PerkinElmer Announces Financial Results for the Second Quarter of 2016 | 67 | 1 |
| 6.5 Aug 03, 2016: NanoString Technologies Releases Operating Results for Second Quarter of 2016 | 68 | 1 |
| 6.6 Aug 02, 2016: Pfizer Reports Second-Quarter 2016 Results | 69 | 5 |
| 6.7 Jul 27, 2016: PerkinElmer Elects Frank Witney to Board of Directors | 74 | 1 |
| 6.8 Jul 13, 2016: Pfizer and NovaMedica announce a strategic partnership in Russia | 74 | 1 |
| 6.9 Jul 12, 2016: PerkinElmer Raises USD552.3 Million in Public Offering of 1.875% Senior Notes Due 2026 | 75 | 1 |
| 6.10 Jul 07, 2016: IntegraGen reports strong revenue growth during first half of 2016 | 76 | 1 |
| 6.11 Jul 04, 2016: Oncimmune Enters into Research Agreement with Egybiotech and Aarhus University Hospital | 76 | 1 |
| 6.12 Jun 27, 2016: ProMIS Neurosciences Raises USD0.8 Million in Private Placement of Units | 76 | 1 |
| 6.13 Jun 23, 2016: Oncimmune Appoints Julian Hirst as Non-Executive Director | 77 | 1 |
| 6.14 Jun 16, 2016: Pfizer Breaks Ground On New Biologics Clinical Manufacturing Facility In Andover, Massachusetts | 77 | 1 |
| 6.15 Jun 02, 2016: NanoString Technologies Highlights Advances in Precision Oncology and Immunotherapy at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) | 78 | 3 |
| 6.16 Jun 01, 2016: Royal Philips Enters into Research Agreement with Yale School of Medicine | 81 | 1 |
| 6.17 Jun 01, 2016: Proteome Sciences Announces CEO Appointment | 81 | 1 |
| 6.18 May 31, 2016: Pfizer Raises USD1.25 Billion in Public Offering of 1.2% Notes Due 2018 | 82 | 1 |
| 6.19 May 31, 2016: Pfizer Raises USD0.85 Billion in Public Offering of 1.45% Notes Due 2019 | 82 | 1 |
| 6.20 May 31, 2016: Pfizer Raises USD1.15 Billion in Public Offering of 1.95% Notes Due 2021 | 83 | 1 |
| 6.21 May 31, 2016: Pfizer Raises USD1.25 Billion in Public Offering of 2.75% Notes Due 2026 | 83 | 1 |
| 6.22 May 31, 2016: Pfizer Raises USD0.5 Billion in Public Offering of 4.4% Notes Due 2044 | 84 | 1 |
| 6.23 May 11, 2016: ProMIS Neurosciences announces first quarter 2016 results | 84 | 1 |
| 6.24 May 10, 2016: Trovagene Announces First Quarter 2016 Financial Results | 85 | 1 |
| 6.25 May 10, 2016: Blueprint Medicines Reports First Quarter 2016 Financial Results | 86 | 2 |
| 6.26 Apr 27, 2016: A.G. Schneiderman Announces Multistate And Federal Settlement With Wyeth And Pfizer For $784.6m To Resolve Allegations Of Underpaying Rebates Owed Through The Medicaid Drug Rebate Program | 88 | 1 |
| 6.27 Mar 07, 2016: Blueprint Medicines Enters into Co-Development Agreement with Ventana Medical Systems | 89 | 1 |
| 6.28 Dec 02, 2015: Surefire Medical Raises USD15 Million in Series C Financing | 89 | 1 |
| 6.29 Oct 27, 2015: Simple blood test measures risk of liver cancer | 89 | 1 |
| 6.30 Sep 21, 2015: Veran Medical Raises USD30.6 Million in Venture Financing | 90 | 1 |
| 6.31 Sep 09, 2015: Quirem Medical Raises Funds through Private Placement of Shares | 90 | 1 |
| 7 Appendix | 91 | 4 |
| 7.1 Methodology | 91 | 2 |
| 7.2 About GlobalData | 93 | 1 |
| 7.3 Contact Us | 94 | 1 |
| 7.4 Disclaimer | 94 | 1 |